These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 19094812)

  • 1. [Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)].
    Lobo I; Ferreira M; Velho G; Sanches M; Selores M
    Acta Med Port; 2008; 21(4):367-72. PubMed ID: 19094812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DRESS syndrome: the great clinical mimicker.
    Fleming P; Marik PE
    Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine-induced DRESS.
    Teo L; Tan E
    Singapore Med J; 2006 Mar; 47(3):237-9. PubMed ID: 16518561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia.
    Vaida I; Roszkiewicz F; Gruson B; Makdassi R; Damaj G
    Pharmacology; 2009; 83(3):148-9. PubMed ID: 19122478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening acute adverse cutaneous drug reactions.
    Wolf R; Orion E; Marcos B; Matz H
    Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-induced DRESS syndrome in a female patient.
    Vauthey L; Uçkay I; Abrassart S; Bernard L; Assal M; Ferry T; Djordjevic M; Roussos C; Vaudaux P
    Pharmacology; 2008; 82(2):138-41. PubMed ID: 18607115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
    Barbaud A
    Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticonvulsant hypersensitivity syndrome in children].
    Pinheiro AE; Ferreira R; Ferreira GC; Varandas L
    Acta Med Port; 2010; 23(4):715-8. PubMed ID: 20688003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
    Kano Y; Shiohara T
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.
    Walsh SA; Creamer D
    Clin Exp Dermatol; 2011 Jan; 36(1):6-11. PubMed ID: 21143513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update.
    Tas S; Simonart T
    Dermatology; 2003; 206(4):353-6. PubMed ID: 12771485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.
    Ganeva M; Gancheva T; Lazarova R; Troeva J; Baldaranov I; Vassilev I; Hristakieva E; Tzaneva V
    Int J Dermatol; 2008 Aug; 47(8):853-60. PubMed ID: 18717872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital].
    Lachgar T; Touil Y
    Allerg Immunol (Paris); 2001 Apr; 33(4):173-5. PubMed ID: 11434197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.
    Yun SJ; Lee JB; Kim EJ; Quan G; Kim SJ; Won YH; Lee SC
    Acta Derm Venereol; 2006; 86(3):241-4. PubMed ID: 16710584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    D'Orazio JL
    Clin Toxicol (Phila); 2008 Dec; 46(10):1093-4. PubMed ID: 18821094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.